CoreAge Rx GLP-1 Review (2026): Pricing, Coverage, and Tradeoffs

Item: CoreAge Rx
Author: RangeYourself

CoreAge Rx review. We publish no price for CoreAge Rx: the figures it advertises conflict across its own pages and rest on a basis it does not publish. Shoppers who specifically want a program that states its price does not rise as the GLP-1 dose escalates: CoreAge makes that claim explicitly in its own FAQ. Independent 2026 review from RangeYourself.

By RangeYourselfLast verified 2026-08-08

Quick take

CoreAge Rx is compounded semaglutide and tirzepatide (once-weekly injection), plus separate 'micro dosing' semaglutide and tirzepatide products; alongside sermorelin, nad+ injectable and nad+ nasal spray, an ed product ('4play'), a five-product compounded skin line and four non-prescription supplements., priced as cash-pay, sold as one-time purchases with a refill plan ladder of 1, 3, 6 and 12 months; per coreage's own refund policy 'the longer the plan you choose, the lower your per-month cost' and the 12-month plan 'is our best per-month price'. coreage states the price does not change as the dose escalates. the only figures it publishes anywhere are 'starting at' / 'from' entry figures, and its affiliate landing page discloses those figures are 'based on a 12-month plan paid in full', the 1-month, 3-month and 6-month per-month prices are never published. its own homepage additionally shows a third, conflicting glp-1 figure in the same section. no single defensible ongoing price exists on the public site, so we publish no coreage rx price at all rather than repeat one of its own conflicting figures.. Best for: Shoppers who specifically want a program that states its price does not rise as the GLP-1 dose escalates: CoreAge makes that claim explicitly in its own FAQ. Watch out for: CoreAge Rx's dose claim and its price claim have to be judged separately. Its FAQ states that “all doses cost the same”, which is unusual and worth quoting, but we have not confirmed it: CoreAge publishes no per-dose price ladder to check it against. The price LEVEL is not verifiable at all. Every figure CoreAge advertises is a “starting at” floor, and its own affiliate landing page discloses in fine print that “Prices shown are starting at, based on a 12-month plan paid in full”, so the advertised monthly figures are a one-year prepay rate and the 1-, 3- and 6-month plan prices are never published anywhere. Its own homepage shows three different GLP-1 entry figures inside a single section. Its refund policy promises a full refund if a provider finds you ineligible while also making the $50–$100 consultation fee non-refundable “even if… Your prescription is not approved”, and it imposes an early-cancellation repricing penalty on the 6- and 12-month plans the advertised rates depend on. No dispensing pharmacy is named and no 503A/503B status is stated

Pricing summary

Price surface last checked: 2026-08-08 (we read the provider’s own pricing pages on this date and found no figure we could stand behind)
All-in monthly cost: No single defensible price, see the pricing notes
Semaglutide: Compounded, advertised 'Start with Semaglutide from $99/mo' with the bullet 'Same price at every dose' (www.coreagerx.com homepage) and 'Starting at $99 per month' (www.coreagerx.com/product/semaglutide/). The SAME homepage section introduces compounded semaglutide and tirzepatide 'from $199/mo'. Per the affiliate landing page's own fine print, 'Prices shown are starting at, based on a 12-month plan paid in full.' No month-to-month rate is published; confirm at enrollment. Read 2026-08-08.
Tirzepatide: Compounded, advertised 'Start with Tirzepatide from $149/mo' with the bullet 'Same price at every dose' (www.coreagerx.com homepage) and 'Starting at $149/mo' (product cards). The SAME homepage section introduces compounded tirzepatide and semaglutide 'from $199/mo'. Per the affiliate landing page's own fine print, 'Prices shown are starting at, based on a 12-month plan paid in full.' No month-to-month rate is published; confirm at enrollment. Read 2026-08-08.
Compounded vs brand-name: Compounded only
Insurance accepted: No insurance-billing path published (cash-pay); confirm at signup
Consult type: Async questionnaire, per the provider’s published flow
Dose-escalation pricing: CoreAge Rx explicitly claims price is INVARIANT to dose: this is its single most distinctive claim and it is stated first-party, twice, in its own FAQ (www.coreagerx.com/faq/, read 2026-08-08): 'Will the monthly price go up later? No. Whatever price you lock in at checkout stays the same for all future months, regardless of dose increases' and 'Do higher doses cost more? No. One of our biggest advantages is that all doses cost the same, so you won't pay more as your treatment escalates.' Its affiliate landing page states the same thing more aggressively ('$149 is $149. On every dose. Every month. Forever.'). RY has NOT independently confirmed this claim: no per-dose price ladder is published anywhere on the site to check it against, and RY did not enter the intake funnel. So this is reported as CoreAge Rx’s own claim, not as a fact we verified. Note that price DOES vary by PLAN TERM even if it does not vary by dose: the refund policy states 'The longer the plan you choose, the lower your per-month cost' and that the 12-month plan 'is our best per-month price', and the 1/3/6-month per-month figures are never published.
Refund policy: Published at www.coreagerx.com/returns-refund-policy/ (rewritten by CoreAge on 2026-08-13 per the page's own dateModified; re-read 2026-09-01). The previous first-party line 'There are no automatic recurring charges or subscriptions' NO LONGER EXISTS on the page. Its replacement, Section 2 ('One-Time Purchases, Subscriptions & Automatic Renewals'), states verbatim: 'CoreAge Rx may offer both one-time purchases and subscription plans with automatic renewals, depending on the treatment or plan you select... By enrolling in an automatically renewing plan, you authorize CoreAge Rx to charge your selected payment method at each applicable renewal until you cancel the subscription.' The FAQ (dateModified 2026-05-01) still says 'no auto-rebills'; the two pages now conflict and the newer policy page governs. The $50-$100 non-refundable provider-consultation fee disclosure remains.
States served: CoreAge Rx publishes no state list. Its FAQ says it 'offers service in the United States only but based on the therapy and medication being prescribed, there may be restrictions based on state', disclosed 'as part of the intake process', confirm your state at signup

Check CoreAge Rx pricing →

Choose CoreAge Rx if

You want a program that states, in its own words, that your price does not rise as your dose escalates
You are comfortable committing to a 12-month plan, which is the basis of every price CoreAge advertises
You are comfortable confirming the real rate at enrollment (CoreAge's own pages show three different GLP-1 entry figures)
You do not need the dispensing pharmacy named, a 503A/503B status, or any third-party testing evidence before you buy

Skip CoreAge Rx if

You want a published month-to-month price, a published plan-price ladder, a named dispensing pharmacy, a stated 503A/503B status, published state availability, or any third-party testing evidence.

Contraindications and clinical notes

CoreAge publishes a dedicated compounded-semaglutide safety page (www.coreagerx.com/important-safety-information-for-compounded-semaglutide/) stating: 'Do not use compounded semaglutide if: You have a personal or family history of medullary thyroid carcinoma (MTC); You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2); You have had a serious hypersensitivity or allergic reaction to semaglutide or any ingredients in the formulation; You are pregnant or planning to become pregnant.' Its FAQ adds that the GLP-1 class 'isn't recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia' and 'is also not recommended if you've had pancreatitis'. On age, CoreAge's FAQ states 'We treat patients 18 years of age and older' and its Terms state 'You must be 18 years of age or older to access or use the Site.' NOTE: no equivalent safety page exists for compounded TIRZEPATIDE: the parallel URL returns HTTP 404, so no tirzepatide-specific FDA-status disclosure exists anywhere on CoreAge's own site.. Talk to a clinician about personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, or other conditions before starting any GLP-1 medication.

Verified programs with a published all-in monthly price

CoreAge Rx’s price on file has not passed our current verification cycle, so it is not compared here. The programs below carry a verified all-in monthly price, checked on each provider’s own pricing page and ranked lowest first as of October 15, 2026.

1.Embody
$69/mo (limited-time promo), verified September 17, 2026
See pricing →
2.HealthRX
$97/mo (12-month Subscribe & Save plan rate), verified October 6, 2026
See pricing →
3.Sprout Health
$99/mo (12-month plan rate), verified October 6, 2026
See pricing →
4.Strut Health
$99/mo (sublingual/oral starting price), verified September 28, 2026
See pricing →
5.Trimi
$99/mo (annual-plan rate), verified August 21, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

How CoreAge Rx compares

Frequently asked questions

How much does CoreAge Rx cost per month?

CoreAge Rx advertises figures, but we publish none of them as its price: they conflict across its own pages and/or rest on a plan basis it does not disclose, so there is no single defensible ongoing rate to quote. The figures it does advertise, and what each one actually rests on, are set out in full below. CoreAge Rx explicitly claims price is INVARIANT to dose: this is its single most distinctive claim and it is stated first-party, twice, in its own FAQ (www.coreagerx.com/faq/, read 2026-08-08): 'Will the monthly price go up later? No. Whatever price you lock in at checkout stays the same for all future months, regardless of dose increases' and 'Do higher doses cost more? No. One of our biggest advantages is that all doses cost the same, so you won't pay more as your treatment escalates.' Its affiliate landing page states the same thing more aggressively ('$149 is $149. On every dose. Every month. Forever.'). RY has NOT independently confirmed this claim: no per-dose price ladder is published anywhere on the site to check it against, and RY did not enter the intake funnel. So this is reported as CoreAge Rx’s own claim, not as a fact we verified. Note that price DOES vary by PLAN TERM even if it does not vary by dose: the refund policy states 'The longer the plan you choose, the lower your per-month cost' and that the 12-month plan 'is our best per-month price', and the 1/3/6-month per-month figures are never published.

Does CoreAge Rx accept insurance?

CoreAge Rx publishes cash-pay prices and we found no insurance-billing path on its own site. Where a provider's own FAQ leaves the door open, the answer sits inside its intake flow, which we do not enter, so confirm at signup rather than treating this as settled. If you want insurance-billed brand-name GLP-1, see our list of GLP-1 programs that accept insurance.

What states does CoreAge Rx serve?

CoreAge Rx publishes no state list. Its FAQ says it 'offers service in the United States only but based on the therapy and medication being prescribed, there may be restrictions based on state', disclosed 'as part of the intake process', confirm your state at signup.

Is CoreAge Rx compounded or brand-name?

CoreAge Rx prescribes compounded semaglutide and tirzepatide via state-licensed 503A pharmacies or 503B outsourcing facilities. Compounded medication is not individually FDA-approved. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so compounding now proceeds under the ordinary rules for individual patients.

What's the catch with CoreAge Rx?

CoreAge Rx's dose claim and its price claim have to be judged separately. Its FAQ states that “all doses cost the same”, which is unusual and worth quoting, but we have not confirmed it: CoreAge publishes no per-dose price ladder to check it against. The price LEVEL is not verifiable at all. Every figure CoreAge advertises is a “starting at” floor, and its own affiliate landing page discloses in fine print that “Prices shown are starting at, based on a 12-month plan paid in full”, so the advertised monthly figures are a one-year prepay rate and the 1-, 3- and 6-month plan prices are never published anywhere. Its own homepage shows three different GLP-1 entry figures inside a single section. Its refund policy promises a full refund if a provider finds you ineligible while also making the $50–$100 consultation fee non-refundable “even if… Your prescription is not approved”, and it imposes an early-cancellation repricing penalty on the 6- and 12-month plans the advertised rates depend on. No dispensing pharmacy is named and no 503A/503B status is stated Avoid if: you want a published month-to-month price, a published plan-price ladder, a named dispensing pharmacy, a stated 503a/503b status, published state availability, or any third-party testing evidence.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. We publish no price for CoreAge Rx: we read its own pricing pages on 2026-08-08 and found no single figure we could stand behind. Confirm the rate directly with the provider.